Paediatric Strongyloidiasis in Central Australia
AbstractFew published studies are available describing the prevalence of paediatric strongyloidiasis in endemic areas within Australia. This literature review and exploratory clinical audit presents the first seroprevalence data for paediatric patients in Central Australia. A total of 16.1% (30/186) of paediatric inpatients tested for Strongyloides stercoralis in 2016 were seropositive (95% CI: 11.5% to 22.1%). Eosinophilia of unknown aetiology was the most common indication for testing (91.9%). Seropositive patients were significantly more likely to reside in communities outside of Alice Springs (p = 0.02). Seropositive patients were noted to have higher mean eosinophil counts with a mean difference of 0.86 × 109/L (95% CI: 0.56 to 1.16, p < 0.0001), although the limited utility of eosinophilia as a surrogate marker of strongyloidiasis has been described previously. All seropositive patients were Indigenous. There was no significant difference in ages between groups. There was a male predominance in the seropositive group, although this was not significant (p = 0.12). Twelve patients had known human T-lymphotropic virus 1 (HTLV-1) status and all were seronegative. Further research describing the epidemiology of strongyloidiasis in Central Australia is required. View Full-Text
Share & Cite This Article
Wilson, A.; Fearon, D. Paediatric Strongyloidiasis in Central Australia. Trop. Med. Infect. Dis. 2018, 3, 64.
Wilson A, Fearon D. Paediatric Strongyloidiasis in Central Australia. Tropical Medicine and Infectious Disease. 2018; 3(2):64.Chicago/Turabian Style
Wilson, Angela; Fearon, Deborah. 2018. "Paediatric Strongyloidiasis in Central Australia." Trop. Med. Infect. Dis. 3, no. 2: 64.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.